Xenetic Biosciences, Inc.XBIONASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank77
5Y CAGR+99.4%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
+99.4%/yr
Long-term compound
Percentile
P77
Within normal range
vs 5Y Ago
31.6x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 31.52% |
| 2023 | 20.06% |
| 2022 | -8.63% |
| 2021 | -11.03% |
| 2020 | 33.32% |
| 2019 | 1.00% |
| 2018 | -535.30% |
| 2017 | 116.87% |
| 2016 | -66.04% |
| 2015 | 57.19% |